LMF Acquisition Opportunities Inc Contracts & Agreements

Employment Agreement, dated January 10, 2024, by and between the Company and David Green (Filed With SEC on January 11, 2024)

Letter Agreement, dated August 30, 2023, by and between the Company and 3i, LP (Filed With SEC on August 30, 2023)

Share Issuance and Settlement Agreement, dated as of June 6, 2023, by and between SeaStar Medical Holding Corporation and Vellar Opportunity Fund SPV LLC - Series 4 (Filed With SEC on August 14, 2023)

Third Amendment, Consent and Waiver Agreement, dated August 7, 2023, by and between the Company and LMFAO Sponsor, LLC (Filed With SEC on August 8, 2023)

Third Amendment, Consent and Waiver Agreement, dated August 7, 2023, by and between the Company and LM Funding America, Inc (Filed With SEC on August 8, 2023)

Third Amendment, Consent and Waiver Agreement, dated August 7, 2023, by and between the Company and Maxim Group LLC (Filed With SEC on August 8, 2023)

Letter Agreement, dated August 7, 2023, by and between the Company and 3i, LP (Filed With SEC on August 8, 2023)

First Amendment to Registration Rights Agreement, dated August 7, 2023, by and between the Company and 3i, LP (Filed With SEC on August 8, 2023)

First Amendment to Securities Purchase Agreement, dated August 7, 2023, by and between the Company and 3i, LP (Filed With SEC on August 8, 2023)

Share Issuance and Settlement Agreement, dated as of June 6, 2023, by and among SeaStar Medical Holding Corporation and Vellar Opportunity Fund SPV LLC Series 4 (Filed With SEC on July 20, 2023)

Form of Senior Unsecured Convertible Note (Filed With SEC on March 16, 2023)

Registration Rights Agreement (Filed With SEC on March 16, 2023)

Securities Purchase Agreement (Filed With SEC on March 16, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on March 16, 2023)

Amendment No. 1 to Registration Rights Agreement, dated as of November 9, 2022, by and among Tumim Stone Capital LLC, SeaStar Medical, Inc., and SeaStar Medical Holding Corporation (Filed With SEC on November 10, 2022)

Amendment No. 1 to Common Stock Purchase Agreement, dated as of November 9, 2022, by and among Tumim Stone Capital, LLC, SeaStar Medical, Inc., and SeaStar Medical Holding... (Filed With SEC on November 10, 2022)

Intercreditor Agreement, dated October 28, 2022, by and among Maxim Group LLC, LM Funding America, Inc., LMFAO Sponsor, LLC, SeaStar Medical, Inc. and SeaStar Medical Holding... (Filed With SEC on November 4, 2022)

Promissory Note, dated October 28, 2022, issued by SeaStar Medical Holding Corporation to Maxim Group LLC (Filed With SEC on November 4, 2022)

Guaranty, dated October 28, 2022, issued by SeaStar Medical, Inc. to LMFAO Sponsor, LLC (Filed With SEC on November 4, 2022)

Security Agreement, dated October 28, 2022, issued by SeaStar Medical, Inc. and SeaStar Medical Holding Corporation to LMFAO Sponsor, LLC (Filed With SEC on November 4, 2022)

Consolidated Amended and Restated Promissory Note, dated October 28, 2022, issued by SeaStar Medical Holding Corporation to LMFAO Sponsor, LLC (Filed With SEC on November 4, 2022)

Guaranty, dated October 28, 2022, issued by SeaStar Medical Holding Corporation to LM Funding America, Inc (Filed With SEC on November 4, 2022)

Security Agreement, dated October 28, 2022, issued by SeaStar Medical, Inc. and SeaStar Medical Holding Corporation to LM Funding America, Inc (Filed With SEC on November 4, 2022)

Amended and Restated Promissory Note, dated October 28, 2022, issued by SeaStar Medical, Inc. to LM Funding America, Inc (Filed With SEC on November 4, 2022)

First Amendment to Credit Agreement, dated October 28, 2022, by and between SeaStar Medical, Inc. and LM Funding America, Inc (Filed With SEC on November 4, 2022)

Director Nomination Agreement, dated as of October 28, 2022, by and among LMFAO Sponsor LLC and LMAO (Filed With SEC on November 4, 2022)

Letter Agreement, dated October 28, 2022, by and among LMAO, SeaStar Medical, Inc., and Tumim Stone Capital LLC (Filed With SEC on November 4, 2022)

Amendment No. 1 to Amended and Restated Registration Rights Agreement and Waiver of Lock-up Period, dated October 25, 2022, by and among LMAO and the investors listed on the... (Filed With SEC on November 4, 2022)

Specimen Common Stock Certificate (Filed With SEC on November 4, 2022)

Confirmation for Prepaid Forward Transaction, dated October 26, 2022, by and among LMF Acquisition Opportunities, Inc., SeaStar Medical, Inc. and HB Strategies LLC (Filed With SEC on October 27, 2022)

Confirmation for Prepaid Forward Transaction, dated October 17, 2022, by and among LMF Acquisition Opportunities, Inc., SeaStar Medical, Inc. and Vellar Opportunity Fund SPV LLC -... (Filed With SEC on October 17, 2022)

Promissory Note dated July 29, 2022 between LMFAO Sponsor LLC and LMF Acquisition Opportunities Inc (Filed With SEC on August 16, 2022)

Amended and Restated Promissory Note, dated July 28, 2022, issued by LMF Acquisition Opportunities, Inc. to LMFAO Sponsor, LLC (Filed With SEC on August 1, 2022)

Promissory Note dated effective as of March 1, 2022 between LMFAO Sponsor LLC and LMF Acquisition Opportunities Inc (Filed With SEC on May 19, 2022)

Third Amendment to License Agreement, between CytoPherx, Inc. and the Regents of the University of Michigan, dated July 31, 2014 (Filed With SEC on May 16, 2022)

Form of Warrant to Purchase Preferred Stock of CytoPherx, Inc (Filed With SEC on May 16, 2022)

License Agreement, between Nephrion, Inc. and the Regents of the University of Michigan, dated October 16, 2007 (Filed With SEC on May 16, 2022)

Amended and Restated License Agreement, between Nephrion, Inc. and the Regents of the University of Michigan, dated October 17, 2007 (Filed With SEC on May 16, 2022)

First Amendment to License Agreement, between CytoPherx, Inc. and the Regents of the University of Michigan, dated March 22, 2011 (Filed With SEC on May 16, 2022)

Second Amendment to License Agreement, between CytoPherx, Inc. and the Regents of the University of Michigan, dated August 8, 2013 (Filed With SEC on May 16, 2022)

Fourth Amendment to License Agreement, between CytoPherx, Inc. and the Regents of the University of Michigan, dated June 20, 2016 (Filed With SEC on May 16, 2022)

Fifth Amendment to License Agreement, between SeaStar Medical, Inc. and the Regents of the University of Michigan, dated December 19, 2019 (Filed With SEC on May 16, 2022)

Sixth Amendment to License Agreement, between SeaStar Medical, Inc. and the Regents of the University of Michigan, dated August 20, 2020 (Filed With SEC on May 16, 2022)

Seventh Amendment to License Agreement, between SeaStar Medical, Inc. and the Regents of the University of Michigan, dated March 20, 2022 (Filed With SEC on May 16, 2022)

Registration Rights Agreement, dated January 25, 2021, among the Company, the Sponsor and Maxim Partners LLC (Filed With SEC on January 28, 2021)

Underwriting Agreement, dated as of January 25, 2021, between the Company and Maxim Group LLC (Filed With SEC on January 28, 2021)

Warrant Agreement, dated January 25, 2021, between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on January 28, 2021)

Letter Agreement, dated January 25, 2021, among the Company and its officers, its directors and the Sponsor (Filed With SEC on January 28, 2021)

Investment Management Trust Agreement, dated January 25, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on January 28, 2021)

Private Placement Warrants Purchase Agreement, dated January 25, 2021, between the Company and the Sponsor (Filed With SEC on January 28, 2021)

Form of Indemnity Agreement (Filed With SEC on January 19, 2021)

Form of Private Placement Warrants Purchase Agreement between the Registrant and LMFAO Sponsor, LLC (Filed With SEC on January 19, 2021)

Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on January 19, 2021)

Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant (Filed With SEC on January 19, 2021)

Form of Letter Agreement among the Registrant and our officers, directors, and LMFAO Sponsor, LLC (Filed With SEC on January 19, 2021)

Specimen Warrant Certificate (included in Exhibit 4.4) (Filed With SEC on January 19, 2021)

Specimen Class A common stock Certificate (Filed With SEC on January 19, 2021)

Specimen Unit Certificate (Filed With SEC on January 19, 2021)

Form of Underwriting Agreement (Filed With SEC on January 19, 2021)

Promissory Note, dated November 6, 2020, issued to LMFAO Sponsor, LLC (Filed With SEC on January 8, 2021)

Securities Subscription Agreement, dated November 6, 2020 between the Registrant and LMFAO Sponsor, LLC (Filed With SEC on January 8, 2021)

Category

Industry

Companies

Contracts

LMF Acquisition Opportunities Inc Contracts & Agreements